Cell Based Assays

Cell Based Assays
Product Description

Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes cell based assays. Expertise in cell biology enables us to implement, validate and perform cell-based assays (cba) for several applications like potency assays or neutralizing antibodies. Kymos work with cells from primary cell lines, established cell lines obtained from cell banks of the clients and cultured at kymos or with different kind of cells, for example immortalized cells lines or commercial arrested cell lines. Contact us for more information.

Kymos Pharma Services, S.L.

  • ES
  • 2016
    On CPhI since
  • 4
    Certificates
  • 100 - 249
    Employees
Contract Service
Specifications
  • Selling Points
    Product Features; Quality Service
  • Supplied from
    Spain

Kymos Pharma Services, S.L.

  • ES
  • 2016
    On CPhI since
  • 4
    Certificates
  • 100 - 249
    Employees
Contract Service

More Products from Kymos Pharma Services, S.L.

  • Bioanalysis of Small Molecules

    Product Bioanalysis of Small Molecules

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes bioanalysis of small molecules. Kymos offer bioanalytical method development and validation of innovative small molecules by mass spectrometry. It has the experience of being the selected partner for different companies for the development of proprietary methods from the start-up of a project to the market. Features - research: in vitro and in vivo admet studies, early development: preliminar pharmacokinetics, regulatory preclinical in different species: toxicokinetics, phramacokinetics, pharmacodynamics, phase i studies: parmacokinetics, dose searching studies, single and repeated dose, phase ii to iv clinical studies: related biomarkers, interaction with concomitant medication and feed. Contact us for more information.
  • Immunogenicity

    Product Immunogenicity

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes immunogenicity. Kymos have develops new bioanalytical methods for immunogenicity studies of proteins and peptides following ema and fda guidelines on immunogenicity of therapeutic proteins. Depending on the purpose and the stage of the research project, different studies should be performed: determination of binding antibodies: screening, confirmatory and titration, neutralizing antibodies, antibody typology, cellular immune response. Contact us for more information.
  • Method Development, Validation and Transfer

    Product Method Development, Validation and Transfer

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes method development, validation and transfer. Kymos has comprehensive knowledge in the development and validation of analytical proprietary and non-proprietary methods for excipients, apis, intermediate products and finished products, according to the ich q2 (r1) and fda guidelines and using qbd strategies to improve the results. Their methods are ready for transfer to contract-giver, in compliance with eu-gmp chapter 6, performing a comparative test, a co-validation in two sites or a revalidation. Contact us for more information.
  • Bioequivalence Studies

    Product Bioequivalence Studies

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes bioequivalence studies. Kymos are experts in bioanalysis for bioequivalence studies in collaboration with the sponsor and/or the selected clinical phase center. It has a long list of validated bioanalytical methods and when not available, it performs the method validation free of charge for clients in a very short period of time. Moreover, kymos are also a well-reputed service provider for the full management of bioequivalence studies thanks to strategic alliances with reliable gcp compliance clinical phase centers. Contact us for more information.
  • Percutaneous Absorption

    Product Percutaneous Absorption

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes percutaneous absorption. Kymos shows their experience in studies of percutaneous absorption for topical semisolid drug products using vertical diffusion cells (o franz cells). Both in vitro release test and in vitro permeation test are offered. Contact us for more information.
  • Absorption studies of Dietary Suplements and Phytopharmaceuticals

    Product Absorption studies of Dietary Suplements and Phytopharmaceuticals

    Kymos Pharma Services, S.L. offers wide range of bionalysis services in medicinal chemistry which includes absorption studies of dietary suplements and phytopharmaceuticals. It performs the bioanalysis of active ingredients in biological samples coming from clinical studies of nutraceuticals, medical devices or phytopharmaceuticals. Moreover kymos offer the full management of such studies thanks to a strategic partner for clinical activities: ethical committe approval, recruiting, administration to volunteers, sample collection, bioanalysis and clinical report. Contact us for more information.
  • Analysis of Inhalation drug products

    Product Analysis of Inhalation drug products

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes analysis of inhalation drug products. The devices used for inhaled and nasal drug delivery are collectively referred to as orally inhaled and nasal drug products (oindps). The range of products available is broad, encompassing inhalers (metereddose, dry powder and aqueous droplet), nebulisers (jet, ultrasonic and vibrating mesh) and nasal (aqueous based, dry powder and propellant based). Two of the main factors largely recognised as critical quality attributes in the testing of oindps are delivered dose and particle size. Contact us for more information.
  • Analytical Chemistry

    Product Analytical Chemistry

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes analytical chemistry. Kymos has wide experience in performing analytical tests of raw materials, apis, intermediate products, finished products, packaging materials and process environment samples. The most suitable method is used, according to customer specifications or the relevant pharmacopoeias description (ep, usp, bp, jp). If non-compendial methods should be used, kymos performs the method development and validation from scratch or the method transfer from the manufacturer. However, if compendial methods should be employed, a suitability test or a partial validation can be acceptable. Contact us for more information.
  • Batch Testing & Batch Release

    Product Batch Testing & Batch Release

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes batch testing & batch release. Features: apis certificate of analysis according to the relevant pharmacopoeias, individual parameter determination to be included in batch certificate of analysis, full analysis of all parameters to issue a stand alone batch certificate of analysis, batch testing and batch release of clinical batches, batch testing and batch release of marketing batches, importation into the eu of medicinal drug products (human, veterinary or investigational). Contact us for more information.
  • Characterization of Biologics and Biosimilars

    Product Characterization of Biologics and Biosimilars

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes characterization of biologics and biosimilars. It includes range of biologics such as: hormones and toxins, biosimilars (proteins and monoclonal antibodies), innovative proteins or innovative monoclonal antibodies, antibody drug conjugates, therapeutic peptides: innovative, generic and hybrid formulations, polysaccharides: heparin and others, non-living vaccines. Contact us for more information.
  • Cleaning Validation

    Product Cleaning Validation

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes cleaning validation. It is a relevant gmp activity to prevent contamination of biopharmaceutical products by ensuring that the processing equipment is suitable for following manufacturing processes. Potential contaminants include residues of the active pharmaceutical ingredients or their related substances, and residues from the products used during the cleaning process such as solvents or detergents. This is particullary important for highly-sensitizing compounds such as antibiotics, hormones and cytotoxics and in the case of parenteral drug products. Contact us for more information.
  • Elemental Impurities

    Product Elemental Impurities

    Kymos Pharma Services, S.L. offers wide range of chemistry, manufacturing & control analytical services in medicinal chemistry which includes Elemental Impurities. We provide Elemental Impurities testing using ICP-MS according to ICH Q3D and European Pharmacopoeia and USP General Chapters <232>, <233> and <2232> for drug substances, excipients and drug products, including the 24 elements listed in the ICH Q3D guideline and/or others.

Kymos Pharma Services, S.L. resources

  • News Kymos Acquires Germany’s Prolytic

    Kymos, a Contract Research Organisation (CRO) and member of CataloniaBio & HealthTech, has bought German company Prolytic GmbH in order to strengthen its activity in the biologics and advanced therapies market. The company previously acquired Italian firm Pharmaprogress in 2016.
  • Brochure KYMOS: Adding Value to Biopharma

    KYMOS recently had the pleasure to lead a TV program series about the importance of outsourcing service providers like ourselves in the provision of medicines. Since the outbreak of COVID-19 the general public is paying much more attention to the biopharmaceutical industry and the challenges of conducting drug development, manufacturing, quality control and supply in the midst of a global pandemic. We invite you to watch this 2-minute English video and celebrate society's rising awareness of the key role played by the pharma and biotech sectors in our day-to-day lives.

Recommended products